Gaviscon

Gaviscon is a United Kingdom-origin over-the-counter gastrointestinal medicine brand focused on the symptomatic relief of heartburn, acid reflux and indigestion. Its products are generally associated with formulations that combine antacid ingredients with alginic acid or alginate. The antacid component helps neutralize gastric acid, while alginate can form a floating barrier or raft above stomach contents, helping limit the movement of acid into the esophagus. This mechanism differentiates Gaviscon from medicines whose primary action is to suppress acid production, such as proton-pump inhibitors and H2-receptor antagonists. The brand is sold in multiple dosage forms, including oral liquids and chewable tablets. Depending on the market and product variant, formulations may contain combinations of alginate, carbonate or bicarbonate salts, and other antacid ingredients. Product composition, indications, labeling and availability vary by country. Gaviscon is commonly positioned for short-term, occasional symptoms rather than as a substitute for medical assessment of persistent or severe gastrointestinal symptoms. Gaviscon operates within the broader antacid category. Antacids are typically used for rapid, symptomatic relief because they act in the stomach rather than directly treating the underlying causes of chronic reflux disease. The brand's positioning emphasizes convenient, accessible relief and a physical barrier against reflux in addition to acid neutralization. Liquid products may be preferred by consumers seeking rapid administration, while chewable tablets offer portability and convenience. The brand is associated with Reckitt, the consumer-health company whose portfolio includes over-the-counter medicines and other self-care products. It is marketed in the United Kingdom and has had international availability, although exact formulations, regulatory status, pack names and commercial ownership arrangements can differ across territories. No reliable source in the supplied material establishes a founding year, original inventor, headquarters, financial performance, executive roster or a single global website for the brand. As with other antacid products, appropriate use depends on the formulation and the user's circumstances. Antacids can interact with some oral medicines, including certain antibiotics and mineral supplements, because changes in gastric acidity or binding can reduce absorption. Users with recurring symptoms, difficulty swallowing, unexplained weight loss, bleeding, persistent pain or symptoms requiring frequent treatment may require professional medical advice. Gaviscon therefore occupies both a consumer-health and regulated-medicine position: it is widely recognized as an accessible self-care brand, but its claims and product composition remain subject to country-specific medicine and labeling rules.

Gaviscon belongs to the antacid and gastrointestinal self-care market. Its distinctive product proposition is based on combining conventional acid-neutralizing ingredients with alginate. In the stomach, alginate-containing formulations can create a less dense layer over gastric contents. This is commonly described as a raft or barrier, intended to reduce the upward movement of acidic material toward the esophagus. The antacid ingredients address existing acidity, while the barrier concept addresses reflux mechanics. This positioning places Gaviscon between traditional antacid products and broader reflux-treatment medicines. Conventional antacids work by chemically neutralizing gastric acid and are generally intended to provide relatively rapid relief of occasional symptoms. By contrast, medicines such as H2-receptor antagonists and proton-pump inhibitors primarily reduce acid secretion. Gaviscon's consumer proposition is therefore not simply that it is an antacid, but that it offers a combined approach for symptoms in which reflux is prominent. The brand is represented in oral liquid and chewable formats. Liquids can be easier to swallow and may act quickly because they do not first need to disintegrate like a solid dosage form. Chewable tablets provide a portable alternative. Markets may use different variant names and active-ingredient combinations, and the same product family can be regulated or labeled differently in different jurisdictions. These differences make it inappropriate to treat every Gaviscon product as chemically identical. Gaviscon is associated with Reckitt and forms part of the company's consumer-health activities. Its commercial role is that of a branded, readily available self-care medicine competing in the heartburn, indigestion and reflux-relief category. The supplied reference material does not establish the brand's original launch date, founder, acquisition history, detailed corporate structure or a complete chronology of marketing campaigns. Those items are consequently left undocumented rather than inferred. The wider antacid category has important usage limitations. Antacids may interact with medicines such as tetracycline and fluoroquinolone antibiotics, iron and some other oral drugs. Spacing administration can sometimes be advised, but the appropriate interval depends on the medicine and formulation. Sodium content, mineral ingredients and other excipients can also matter for particular users. Because Gaviscon products differ by country, consumers should follow the label for the specific product and seek medical advice when symptoms are persistent, severe or atypical.

An accessible over-the-counter reflux and heartburn brand combining acid neutralization with an alginate barrier concept. Product names and exact formulations vary by market.

• Gaviscon oral liquidsoral liquid antacid

  Liquid Gaviscon preparations are intended for oral use in the symptomatic relief of heartburn, acid reflux and indigestion. They are associated with alginate-and-antacid formulations, in which alginate can form a surface barrier over stomach contents while antacid salts help neutralize acid. Exact active ingredients, strengths, dosage instructions and regulatory indications vary by market.

• Gaviscon chewable tabletschewable antacid tablet

  Chewable Gaviscon tablets provide a portable solid-dose option for consumers seeking relief from occasional heartburn, reflux or indigestion. The category is associated with combinations of alginate and acid-neutralizing salts. Product composition and approved claims are market-specific, so the tablets should be used according to the labeling for the particular pack.

1. Antacid